SCHEMBL7461429

SCHEMBL7461429

COCn1cnc2c1c(=O)[nH]c(=O)n2C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 3/20 0.60
▸ CYP3A4 P08684 1/20 0.60
▸ PMP22 Q01453 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.59
▸ KDM4E B2RXH2 1/20 0.57
▸ LMNA P02545 1/20 0.57
▸ POLB P06746 1/20 0.57
▸ PDE4A P27815 4/20 0.52
▸ ADORA2A P29274 4/20 0.52
▸ PDE4B Q07343 4/20 0.52
▸ PDE4C Q08493 4/20 0.52
▸ PDE4D Q08499 4/20 0.52
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ BRD4 O60885 4/20 0.49
▸ BRD2 P25440 2/20 0.49
▸ BRD3 Q15059 2/20 0.49
▸ BRDT Q58F21 2/20 0.49
▸ ADORA2B P29275 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7454900 0.87 SMN1; SMN2 (0.61) MAPK1CYP3A4PMP22SMN1; SMN2KDM4E
SCHEMBL7464093 0.86 MAPK1 (0.57) MAPK1CYP3A4PMP22SMN1; SMN2KDM4E
SCHEMBL381684 0.83 PDE4A (0.71) MAPK1CYP3A4PMP22SMN1; SMN2KDM4E
SCHEMBL1495090 0.82 PDE4A (0.76) MAPK1CYP3A4PMP22SMN1; SMN2KDM4E
SCHEMBL10955005 0.82 MAPK1 (0.64) MAPK1CYP3A4PMP22SMN1; SMN2KDM4E
SCHEMBL16675435 0.82 MAPK1 (0.64) MAPK1CYP3A4PMP22SMN1; SMN2KDM4E
SCHEMBL17609493 0.81 SMN1; SMN2 (0.55) MAPK1CYP3A4PMP22SMN1; SMN2KDM4E
SCHEMBL17682216 0.81 SMN1; SMN2 (0.64) MAPK1CYP3A4PMP22SMN1; SMN2KDM4E
SCHEMBL9391065 0.79 MAPK1 (0.60) MAPK1CYP3A4PMP22SMN1; SMN2KDM4E
SCHEMBL4566277 0.79 MEN1 (0.77) MAPK1CYP3A4PMP22SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0771813-B1 Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines HOECHST AG (DE) 2002-01-16 — — EP disclosed
US-5783647-A POLYMERIZATION CATALYST FOR VINYL CHLORIDE POLYMERS, SHORTER REACTION TIMES, IMPROVED COLOR AND LESS ODOR WHEN MOLDED SHIN-ETSU CHEMICAL CO., LTD. (JP) 1998-07-21 — — US disclosed
US-5728686-A TREATMENT OF MUSCULAR DYSTROPHY HOECHST AKTIENGESELLSCHAFT (DE) 1998-03-17 — — US disclosed
US-5710272-A INCREASING CEREBRAL BLOOD FLOW HOECHST AKTIENGESELLSCHAFT (DE) 1998-01-20 — — US disclosed
EP-0771813-A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1997-05-07 — — EP disclosed
EP-0435152-B1 Process for the enantioselective preparation of (omega-1)-hydroxyalkylxanthines HOECHST AG (DE) 1996-11-13 — — EP disclosed
US-5472873-A Rhodotorula rubra useful in a process for the preparation of (ω-1)-hydroxyalkylxanthines HOECHST AKTIENGESELLSCHAFT (DE) 1995-12-05 — — US disclosed
US-5310666-A Vascular disorders HOECHST AKTIENGESELLSCHAFT (DE) 1994-05-10 — — US disclosed
EP-0435152-A2 Process for the enantioselective preparation of (omega-1)-hydroxyalkylxanthines HOECHST AKTIENGESELLSCHAFT (DE) 1991-07-03 — — EP disclosed
Send feedback